To further illuminate the relationship between MINA53 and glioblastoma cell DNA damage and cell death, we applied a DNA damage-inducing agent Doxorubicin (an efficient DSB inducing chemotherapy medication widely used in cancer) to study whether MINA53 deficiency would sensitize glioblastoma cell to it. Here, RIOX2 is linked to cancer.